Heparin-induced thrombocytopenia and cardiovascular diseases
Open Access
- 1 July 2006
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 152 (1), 19-26
- https://doi.org/10.1016/j.ahj.2005.10.005
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Heparin-induced thrombocytopenia: principles for early recognition and management.Cleveland Clinic Journal of Medicine, 2005
- Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: Study design and rationaleAmerican Heart Journal, 2004
- Bivalirudin, Blood Loss, and Graft Patency in Coronary Artery Bypass SurgerySeminars in Thrombosis and Hemostasis, 2004
- Fondaparinux: a new synthetic and selective inhibitor of Factor XaBest Practice & Research Clinical Haematology, 2004
- Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trialThe Lancet, 1999
- Novastan®(Brand of Argatroban): A Small-Molecule, Direct Thrombin InhibitorSeminars in Thrombosis and Hemostasis, 1997
- Heparin‐induced thrombocytopenia and thrombosis: a prospective analysis of the incidence in patients with heart and cerebrovascular diseasesBritish Journal of Haematology, 1997
- Heparin-Induced Thrombocytopenia and ThrombosisNew England Journal of Medicine, 1995
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Immune Endothelial-Cell Injury in Heparin-Associated ThrombocytopeniaNew England Journal of Medicine, 1987